¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28
±³À°ÀÏÀÚ : 2022-05-28
±³À°Àå¼Ò : ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : 2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤)
ÁÖÃÖ±â°ü : ´ëÇѼҾư¨¿°ÇÐȸ
´ã´çÀÚ : ±è¿µ¶õ
¿¬¶ôó : 02-3478-1668  
À̸ÞÀÏ : kspid@kspid.or.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡   (ÀÏ¹Ý 4Á¡ / Çʼö 1Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í È¸¿ø: 40,000¿øºñȸ¿ø: 60,000¿øÀü°øÀÇ ¹× Çлý: 10,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ10:00~10:30 Recent advances in prevention of RSV in young infants  À±±â¿í(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ10:30~11:00 Advances in development of Influenza vaccines  ±èÀ±°æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ11:00~11:30 Prevention strategies for CMV infection  ÀÌÁø¾Æ(¿ï»êÀÇ´ë) 
±âŸ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ11:30~12:00 ÃÑȸ  () 
½Ä»ç 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ12:00~13:00 Á߽Ġ () 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ13:00~13:40 Past, present, and future of mRNA vaccines  Á¶´ë¼±/TBD(ÀüºÏÀÇ´ë/Moderna) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ13:40~14:20 COVID-19 in children and pregnant women in Japan  Kensuke Shoji(National Center for Child Health and Development) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ14:20~15:00 Clinical features of COVID-19 in children in Korea  Çѹ̼±(¼­¿ïÀÇ´ë) 
È޽Ġ05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ15:00~15:20 È޽Ġ () 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ15:20~15:50 Issues on COVID-19 vaccines in children: effectiveness, safety and goals  ÃÖ¿µÁØ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ15:50~16:20 Surveillance during the COVID-19 pandemic: modeling and monitoring  Á¤ÀçÈÆ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ16:20~16:50 Reflecting on infection control measures in COVID-19: what was necessary and what was not?  Á¶Çý°æ(°¡ÃµÀÇ´ë) 
±âŸ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ16:50~17:00 Çмú³í¹®»ó ¹× PIV ¿ì¼ö ½É»çÀ§¿ø»ó ¼ö»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â Á¦ 82Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2022-05-29
´ÙÀ½±Û 2022 Çѱ¹¸ðÀÚº¸°ÇÇÐȸ Á¦50ȸ Ãá°è¿¬¼ö°­Á : 2022-05-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 3 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 3 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 107 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 9 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 24 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 10 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 5 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 4 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 6 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 9 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷